Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Assess the Long-term Efficacy and Safety of Combined Therapy With Ezefeno Tab. in Patients With Dyslipidemia Who do Not Achieve Adequate Control of Non-HDL-C Levels Even With Moderate-intensity Monotherapy

NCT06293417 is registered in ClinicalTrials.gov with Korea University Anam Hospital as lead sponsor.

NCT NCT06293417
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06293417 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Assess the Long-term Efficacy and Safety of Combined Therapy With Ezefeno Tab. in Patients With Dyslipidemia Who do Not Achieve Adequate Control of Non-HDL-C Levels Even With Moderate-intensity Monotherapy
Lead sponsor
Korea University Anam Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
March 1, 2024
Completion date
February 1, 2027
Enrollment
3,958 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidemias, t2dm (type 2 diabetes mellitus)